Skip to main content

Advertisement

Log in

Atypical clinical manifestations of Miller Fisher syndrome

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Miller Fisher syndrome (MFS) is characterized by a clinical triad of ophthalmoplegia, ataxia, and areflexia, and is closely associated with serum anti-GQ1b antibody. Although the clinical triad is the cardinal diagnostic clue, a variety of other symptoms and signs beyond the triad have been reported. To elucidate the frequency and characteristics of atypical clinical manifestations of MFS, we recruited 38 patients with MFS and evaluated the symptoms or signs beyond the classic triad. Eleven (29%) of 38 patients had atypical clinical manifestations of MFS such as headache (n = 6), delayed facial palsy (n = 3), divergence insufficiency (n = 2), and taste impairment (n = 2). Headache was localized to the periorbital (n = 3), temporal (n = 2), or whole (n = 1) area. Only one of them showed bilateral papilledema and an elevated opening pressure in cerebrospinal fluid analysis. Delayed facial palsy developed after the other signs have reached nadir (n = 1) or started to improve (n = 2), and did not follow a pattern of descending paralysis with other cranial neuropathies. Two patients showed divergence insufficiency without external ophthalmoplegia, and another two had taste impairment over the entire tongue without the other signs of facial and glossopharyngeal nerve involvements. Our study shows that approximately 30% of MFS patients can have atypical clinical manifestations beyond the classic triad. These results reflect the broad clinical spectrum of MFS, and might be associated with the presence of additional antiganglioside antibodies besides anti-GQ1b in patients with MFS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. FISHER M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:57–65

    Article  CAS  Google Scholar 

  2. Wakerley BR, Uncini A, Yuki N (2014) Guillain-Barré and Miller Fisher syndromes - new diagnostic classification. Nat Rev Neurol 10:537–544

    Article  Google Scholar 

  3. Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, Kuwabara S (2016) How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol 23:1058–1063

    Article  CAS  Google Scholar 

  4. Hu Q, Li H, Tian J, Zhang B (2018) Bulbar paralysis associated with Miller-Fisher syndrome and its overlaps in Chinese patients. Neurol Sci 39:305–311

    Article  Google Scholar 

  5. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43:1911–1917

    Article  CAS  Google Scholar 

  6. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I (1997) Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 745:32–36

    Article  CAS  Google Scholar 

  7. Koga M, Yuki N, Hirata K (2000) Pain in Miller Fisher syndrome. J Neurol 247:720–721

    Article  CAS  Google Scholar 

  8. Friedman DI, Potts E (2007) Headache associated with Miller Fisher syndrome. Headache 47:1347–1348

    Article  Google Scholar 

  9. Kim JK, Kim B-J, Shin HY, Shin KJ, Nam TS, Seok JI, Suh BC, Oh J, Kim YJ, Bae JS (2015) Does delayed facial involvement implicate a pattern of “descending reversible paralysis” in Fisher syndrome? Clin Neurol Neurosurg 135:1–5

    Article  Google Scholar 

  10. Tan CY, Yuki N, Shahrizaila N (2015) Delayed facial palsy in Miller Fisher syndrome. J Neurol Sci 358:409–412

    Article  Google Scholar 

  11. Biotti D, Boucher S, Ong E, Tilikete C, Vighetto A (2013) Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome. J Neurol 260:2890–2891

    Article  Google Scholar 

  12. Ohe Y, Shintani D, Kato Y, Tanahashi N (2012) Fisher syndrome with taste impairment. Intern Med 51:2977–2979

    Article  Google Scholar 

  13. Yagi Y, Yokote H, Watanabe Y, Amino T, Kamata T, Kusunoki S (2015) Taste impairment in Miller Fisher syndrome. Neurol Sci 36:809–810

    Article  Google Scholar 

  14. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T (2001) Clinical features and prognosis of Miller Fisher syndrome. Neurology 56:1104–1106

    Article  CAS  Google Scholar 

  15. Meyer W, Schneider B, Nobile Orazio E, Klotz M, Schlumberger W, Stoker W (2002) EUROLINE anti-ganglioside-profile: a new membrane test for detection of antibodies against gangliosides. Autoimmun Rev 1:71

    Google Scholar 

  16. Farmakidis C, Inan S, Milstein M, Herskovitz S (2015) Headache and pain in Guillain-Barré syndrome. Curr Pain Headache Rep 19:40

    Article  Google Scholar 

  17. Lolekha P, Phanthumchinda K (2009) Miller-Fisher syndrome at King Chulalongkorn Memorial Hospital. J Med Assoc Thail 92:471–477

    Google Scholar 

  18. Gold DR, Zee DS (2015) Neuro-ophthalmology and neuro-otology update. J Neurol 262:2786–2792

    Article  Google Scholar 

  19. Pinchoff BS, Slavin ML, Rosenstein D, Hyman R (1986) Divergence paralysis as the initial sign in the Miller Fisher syndrome. Am J Ophthalmol 101:741–742

    Article  CAS  Google Scholar 

  20. Oguro H, Yamaguchi S, Abe S, Bokura H, Kobayashi S (2005) Acute divergence paralysis in the Miller Fisher syndrome. Rinsho Shinkeigaku 45:524–526

    PubMed  Google Scholar 

  21. Mays LE (1984) Neural control of vergence eye movements: convergence and divergence neurons in midbrain. J Neurophysiol 51:1091–1108

    Article  CAS  Google Scholar 

  22. Hüfner K, Frenzel C, Kremmyda O, Adrion C, Bardins S, Glasauer S, Brandt T, Strupp M (2015) Esophoria or esotropia in adulthood: a sign of cerebellar dysfunction? J Neurol 262:585–592

    Article  Google Scholar 

  23. Kim YK, Kim JS, Jeong SH, Park KS, Kim SE, Park SH (2009) Cerebral glucose metabolism in Fisher syndrome. J Neurol Neurosurg Psychiatry 80:512–517

    Article  CAS  Google Scholar 

  24. Blumenfeld H (2010) Neuroanatomy through clinical cases, 2nd edn. Sunderland: Sinauer Associates

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jae-Hwan Choi.

Ethics declarations

All experiments followed the tenets of the Declaration of Helsinki and were approved by the Institutional Review Board of Pusan National University Yangsan Hospital. Informed contents were obtained after the nature and possible consequence of this study had been explained to participants.

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jung, J.H., Oh, E.H., Shin, JH. et al. Atypical clinical manifestations of Miller Fisher syndrome. Neurol Sci 40, 67–73 (2019). https://doi.org/10.1007/s10072-018-3580-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3580-2

Keywords

Navigation